Todd Franklin Watanabe, See Remarks at Arcutis Biotherapeutics, Inc. (ARQT), sold 13,218 shares at $15.82 ($210K) on 2023-03-02, disclosed to the SEC on 2023-03-02.
Seasonal sale ($210k) by See Remarks — this insider has traded ARQT in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.17 | 2,343 | $38K | 18.0% |
| 2 | $15.82 | 5,403 | $85K | 40.7% |
| 3 | $15.82 | 5,403 | $85K | 40.7% |
| 4 | $16.52 | 69 | $1K | 0.5% |
| Total | $15.89 avg | 13,218 | $210K | 100% |
| Filing → |
| ARQT | SELL | 2025-03-20 | $21K | — | Filing → |
| ARQT | SELL | 2025-03-04 | $654K | — | Filing → |
| ARQT | SELL | 2025-02-04 | $490K | — | Filing → |